Research Article
Accelerated antioxidant bioavailability of OPC-3® bioflavonoids administered as isotonic solution
Article first published online: 26 JAN 2009
DOI: 10.1002/ptr.2651
Copyright © 2009 John Wiley & Sons, Ltd.
Additional Information
How to Cite
Cesarone, M. R., Grossi, M. G., Renzo, A. D., Errichi, S., Schönlau, F., Wilmer, J. L., Lange, M. and Blumenfeld, J. (2009), Accelerated antioxidant bioavailability of OPC-3® bioflavonoids administered as isotonic solution. Phytotherapy Research, 23: 775–777. doi: 10.1002/ptr.2651
Publication History
- Issue published online: 21 MAY 2009
- Article first published online: 26 JAN 2009
- Manuscript Revised: 19 JUN 2008
- Manuscript Accepted: 19 JUN 2008
- Manuscript Received: 19 MAY 2008
- Abstract
- References
- Cited By
Keywords:
- flavonoid bioavailability;
- OPC-3®;
- antioxidant;
- isotonic formulation
Abstract
The degree of absorption of bioflavonoids, a diverse and complex group of plant derived phytonutrients, has been a frequent debate among scientists. Monomeric flavonoid species are known to be absorbed within 2 h. The kinetics of plasma reactive oxygen species, a reflection of bioactivity, of a commercial blend of flavonoids, OPC-3® was investigated. OPC-3® was selected to compare absorption of an isotonic flavonoid solution vs tablet form with the equivalent amount of fluid.
In the case of isotonic OPC-3® the reactive oxygen species of the subject's plasma decreased significantly (p < 0.05), six times greater than OPC-3® tablets by 10 min post-consumption. After 20 min the isotonic formulation was approximately four times more bioavailable and after 40 min twice as bioavailable as the tablet, respectively. At time points 1 h and later, both isotonic and tablet formulations lowered oxidative stress, although the isotonic formulation values remained significantly better throughout the investigation period of 4 h. These findings point to a dramatically accelerated bioavailability of flavonoids delivered in an isotonic formulation. Copyright © 2009 John Wiley & Sons, Ltd.

1099-1573/asset/PTR_left.gif?v=1&s=61679c959d6ba2d597f752341613b4d11f86e770)
1099-1573/asset/PTR_right.gif?v=1&s=9ab10d74d00053b89129ee4003616901d34ded47)
1099-1573/asset/cover.gif?v=1&s=6a64569c4c1b0de9f4868274faed96fd9265b457)